Advertisement
Advertisement
U.S. Markets open in 2 hrs 5 mins
S&P Futures
4,056.25 -28.50 (-0.70%) Dow Futures
32,406.00 -175.00 (-0.54%) Nasdaq Futures
12,437.25 -123.00 (-0.98%) Russell 2000 Futures
1,824.40 -12.80 (-0.70%) Crude Oil
113.85 +1.45 (+1.29%) Gold
1,812.60 -6.30 (-0.35%)
Bio-Rad Laboratories, Inc. (BIO)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:03PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 499.09 |
| Open | 507.85 |
| Bid | 455.68 x 1000 |
| Ask | 616.50 x 800 |
| Day's Range | 503.48 - 518.20 |
| 52 Week Range | 468.86 - 832.70 |
| Volume | |
| Avg. Volume | 233,951 |
| Market Cap | 15.382B |
| Beta (5Y Monthly) | 0.91 |
| PE Ratio (TTM) | 2.33 |
| EPS (TTM) | 220.48 |
| Earnings Date | Apr 27, 2022 - May 02, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 711.67 |
- Simply Wall St.
Estimating The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)
How far off is Bio-Rad Laboratories, Inc. ( NYSE:BIO ) from its intrinsic value? Using the most recent financial data...
- Zacks
Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Up
Bio-Rad's (BIO) first-quarter 2022 revenues decline year over year due to lower COVID-related demand.
- Zacks
Bio-Rad Laboratories (BIO) Surpasses Q1 Earnings and Revenue Estimates
Bio-Rad (BIO) delivered earnings and revenue surprises of 76.43% and 3.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
